Ortho Clinical Diagnostics Feb 17, 2022 Amid Investor Skepticism, Ortho Clinical Diagnostics CEO Lays Out Merits of Acquisition by Quidel Premium Feb 16, 2022 Ortho Clinical Diagnostics Q4 Revenues Rise 1 Percent Feb 10, 2022 Ortho Clinical Diagnostics, Hangzhou AllTest Biotech, Others Obtain FDA Clearances in January Jan 12, 2022 JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More Jan 6, 2022 Ortho Clinical Diagnostics Preliminary Q4 Revenues Rise 1 Percent Jan 6, 2022 As Third Year of Pandemic Approaches, Role of SARS-CoV-2 Serology Tests Remains Opaque Premium Jan 6, 2022 Dx IPO Window Widens in 2021 as COVID-19 Testing Provides Jumping Off Point Premium Nov 9, 2021 Ortho Clinical Diagnostics, Siemens Healthineers, Roche, and Others Obtain FDA Clearances in October Nov 3, 2021 Ortho Clinical Diagnostics Q3 Revenues Rise 16 Percent Sep 13, 2021 Roche, Ortho Clinical Diagnostics, Abbott Laboratories, Others Obtain FDA Clearances in August Sep 10, 2021 In Brief This Week: Qiagen, Ortho Clinical Diagnostics, MicroGen Diagnostics, and More Aug 4, 2021 Ortho Clinical Diagnostics Q2 Revenues Rise 26 Percent Jul 26, 2021 Ortho Clinical Gets FDA Emergency Use Authorization for SARS-CoV-2 Total Antibody Test Jul 9, 2021 FDA Grants Emergency Use Authorization for Ortho-Clinical SARS-CoV-2 Quantitative Antibody Assay Jul 7, 2021 Thermo Fisher Scientific, Ortho Clinical Diagnostics Ink Deal for Quality Control Products Jun 30, 2021 Even as Testing Demand Started to Wane, COVID-19 Drove IPOs in Dx Space in H1 2021 Premium May 5, 2021 Ortho Clinical Diagnostics Q1 Revenues Rise 24 Percent on Core Revenue Strength May 5, 2021 Ortho Clinical Diagnostics Obtains CE Mark for Quantitative SARS-CoV-2 Antibody Test Apr 13, 2021 Ortho Clinical Diagnostics Gets Additional CE Mark for Coronavirus Antigen Test Apr 1, 2021 Ortho Clinical Diagnostics to Expand COVID-19 Test Production With $53.7M BARDA, DoD Contract Load More Breaking News BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Careviso Closes $17.4M Series B Funding Round P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test BioAffinity Technologies Nabs $15.6M from Public Offering
